文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.

机构信息

Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China.

Key Laboratory of Chongqing Health Commission for Minimally Invasive and Precise Diagnosis, Chongqing, China.

出版信息

J Hematol Oncol. 2024 Apr 23;17(1):22. doi: 10.1186/s13045-024-01545-6.


DOI:10.1186/s13045-024-01545-6
PMID:38654314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11040947/
Abstract

Tumor is a local tissue hyperplasia resulted from cancerous transformation of normal cells under the action of various physical, chemical and biological factors. The exploration of tumorigenesis mechanism is crucial for early prevention and treatment of tumors. Epigenetic modification is a common and important modification in cells, including DNA methylation, histone modification, non-coding RNA modification and m6A modification. The normal mode of cell death is programmed by cell death-related genes; however, recent researches have revealed some new modes of cell death, including pyroptosis, ferroptosis, cuproptosis and disulfidptosis. Epigenetic regulation of various cell deaths is mainly involved in the regulation of key cell death proteins and affects cell death by up-regulating or down-regulating the expression levels of key proteins. This study aims to investigate the mechanism of epigenetic modifications regulating pyroptosis, ferroptosis, cuproptosis and disulfidptosis of tumor cells, explore possible triggering factors in tumor development from a microscopic point of view, and provide potential targets for tumor therapy and new perspective for the development of antitumor drugs or combination therapies.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/9a08bb72acbc/13045_2024_1545_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/eac917693c91/13045_2024_1545_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/e830da8be04c/13045_2024_1545_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/28ec176f0bfb/13045_2024_1545_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/5fe5c643bed7/13045_2024_1545_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/23d9d181c361/13045_2024_1545_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/9a08bb72acbc/13045_2024_1545_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/eac917693c91/13045_2024_1545_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/e830da8be04c/13045_2024_1545_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/28ec176f0bfb/13045_2024_1545_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/5fe5c643bed7/13045_2024_1545_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/23d9d181c361/13045_2024_1545_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02a1/11040947/9a08bb72acbc/13045_2024_1545_Fig6_HTML.jpg

相似文献

[1]
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.

J Hematol Oncol. 2024-4-23

[2]
Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis.

Redox Biol. 2024-10

[3]
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.

J Hematol Oncol. 2022-12-8

[4]
Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond.

Protein Cell. 2024-9-1

[5]
Novel insights into the interplay between m6A modification and programmed cell death in cancer.

Int J Biol Sci. 2023

[6]
Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: A review.

Int J Biol Macromol. 2025-4

[7]
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs.

J Transl Med. 2023-7-29

[8]
Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.

Nutrients. 2024-4-18

[9]
Ferroptosis regulation by methylation in cancer.

Biochim Biophys Acta Rev Cancer. 2023-11

[10]
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.

Signal Transduct Target Ther. 2023-12-10

引用本文的文献

[1]
Recent advances in copper sulfide nanoparticles for cancer diagnosis and therapy.

Mater Today Bio. 2025-8-13

[2]
FGA modulates immune infiltration and tumor progression via SLC7A11/xCT-mediated disulfidptosis in the tumor microenvironment of lung adenocarcinoma.

Front Immunol. 2025-8-11

[3]
Integrating single-cell and bulk RNA sequencing data to construct a pyroptosis-related prognostic signature and analyze the tumor microenvironment in gastric cancer.

Transl Cancer Res. 2025-7-30

[4]
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy.

Mater Today Bio. 2025-7-29

[5]
Cancer-associated fibroblasts: dual roles from senescence sentinels to death regulators and new dimensions in therapy.

Front Immunol. 2025-7-18

[6]
Ferroptosis-disulfidptosis-related CHMP6 is a clinico-immune target in colorectal cancer.

Biol Direct. 2025-7-21

[7]
Role of in promoting radioresistance in esophageal cancer cells via the inhibition of cuproptosis.

J Thorac Dis. 2025-6-30

[8]
Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation.

J Nanobiotechnology. 2025-7-21

[9]
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies.

Bioact Mater. 2025-7-1

[10]
Prognostic model of lung adenocarcinoma based on disulfidptosis-related genes and analysis of in vitro cell experiments for PPP1R14B in the model.

Biol Direct. 2025-7-1

本文引用的文献

[1]
Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer.

Cancer Lett. 2024-3-1

[2]
Cell death.

Cell. 2024-1-18

[3]
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine.

Cell Death Discov. 2024-1-15

[4]
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via mC modification of SLC7A11 mRNA.

Redox Biol. 2024-2

[5]
MG modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma.

Oncogene. 2024-1

[6]
The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome.

J Inflamm Res. 2023-11-1

[7]
Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis.

Immunity. 2023-11-14

[8]
Lactylation of METTL16 promotes cuproptosis via mA-modification on FDX1 mRNA in gastric cancer.

Nat Commun. 2023-10-20

[9]
Disulfidptosis-associated lncRNAs predict breast cancer subtypes.

Sci Rep. 2023-9-27

[10]
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.

Blood. 2023-12-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索